Medfield Diagnostics AB
Time is of greatest importance when someone gets a stroke. Millions of brain cells die each minute during the first hours. It is today possible to get acute treatment for most strokes. But the treatment cannot be given without a diagnostic step and plenty of time is lost before the diagnosis is set at the hospital.
Medfield’s instrument will be located inside the ambulance. This will cut the time to treatment substantially resulting in huge cost savings for the healthcare system, as well as ensuring that many more stroke victims can keep their speech, and mobility, after a stroke attack.
Medfield’s diagnostic instruments are based on microwave technology. Microwaves scatter compared to x-rays which sets a high demand on data interpretation and algorithms, the core of Medfield’s technology. A clinical study has been completed with Sahlgrenska University Hospital which also resulted in a first reference sale of a Strokefinder R10. Strokefinder M100 for monitoring of TIA patients will be launch in 2013 followed by D1000 for diagnosis in ambulances during 2015.
|Clot or bleeding? Diagnosis is required before treatment can be initiated.||Microwaves scatter, setting high demand
on robust algorithms, the core of Medfield’s technology.
|D1000 for use in ambulances.||Strokefinder R10 in a clinical trial at Sahlgrenska Hospital|